CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Nicotine Replacement Therapy Products
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
4.2.4.1 Nicotine Lozenges Market size and forecast, by region
4.2.4.2 Nicotine Gums Market size and forecast, by region
4.2.4.3 Nicotine Sprays Market size and forecast, by region
4.2.4.4 Nicotine Inhalers Market size and forecast, by region
4.3 Drug Therapy
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 E-cigarettes
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM
5.1 Overview
5.1.1 Market size and forecast
5.2 Gum
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Inhaler
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Tablet
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Online Provider
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug stores and Retail Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.2.3 North America Market size and forecast, by Form
7.2.4 North America Market size and forecast, by Distribution Channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Form
7.2.5.1.3 Market size and forecast, by Distribution Channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Form
7.2.5.2.3 Market size and forecast, by Distribution Channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Form
7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.3.3 Europe Market size and forecast, by Form
7.3.4 Europe Market size and forecast, by Distribution Channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Form
7.3.5.1.3 Market size and forecast, by Distribution Channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Form
7.3.5.2.3 Market size and forecast, by Distribution Channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Form
7.3.5.3.3 Market size and forecast, by Distribution Channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Form
7.3.5.4.3 Market size and forecast, by Distribution Channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Form
7.3.5.5.3 Market size and forecast, by Distribution Channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Form
7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Form
7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Form
7.4.5.1.3 Market size and forecast, by Distribution Channel
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Form
7.4.5.2.3 Market size and forecast, by Distribution Channel
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Form
7.4.5.3.3 Market size and forecast, by Distribution Channel
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Form
7.4.5.4.3 Market size and forecast, by Distribution Channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Form
7.4.5.5.3 Market size and forecast, by Distribution Channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Form
7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.5.3 LAMEA Market size and forecast, by Form
7.5.4 LAMEA Market size and forecast, by Distribution Channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Form
7.5.5.1.3 Market size and forecast, by Distribution Channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Form
7.5.5.2.3 Market size and forecast, by Distribution Channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Form
7.5.5.3.3 Market size and forecast, by Distribution Channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Form
7.5.5.4.3 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 British American Tobacco Plc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 22nd Century group Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cipla Ltd.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Dr. Reddy’s Laboratories Ltd.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 GlaxoSmithKline Plc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Imperial Brands Plc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Johnson and Johnson Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Njoy Company
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Perrigo Company Plc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Pfizer Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Zydus Cadila, Inc.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Rusan Pharma Ltd
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
TABLE 1. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE REPLACEMENT THERAPY PRODUCTS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR NICOTINE REPLACEMENT THERAPY PRODUCTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE LOZENGES, BY REGION, 2021-2031 ($MILLION)
TABLE 6. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE GUMS, BY REGION, 2021-2031 ($MILLION)
TABLE 7. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE SPRAYS, BY REGION, 2021-2031 ($MILLION)
TABLE 8. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR NICOTINE INHALERS, BY REGION, 2021-2031 ($MILLION)
TABLE 9. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR DRUG THERAPY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR DRUG THERAPY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR E-CIGARETTES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR E-CIGARETTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 14. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR GUM, BY REGION, 2021-2031 ($MILLION)
TABLE 15. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR GUM, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR INHALER, BY REGION, 2021-2031 ($MILLION)
TABLE 17. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR INHALER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR TABLET, BY REGION, 2021-2031 ($MILLION)
TABLE 19. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR TABLET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 21. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 23. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 24. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR ONLINE PROVIDER, BY REGION, 2021-2031 ($MILLION)
TABLE 26. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR ONLINE PROVIDER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 28. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 36. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 37. U.S. SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 38. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 40. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 41. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 43. MEXICO SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 44. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 45. EUROPE NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 46. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 47. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 48. EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 49. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 50. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 51. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 52. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 54. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 55. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 57. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 58. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 60. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 61. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 63. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 64. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 66. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 69. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 70. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 72. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 74. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 75. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 76. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 77. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 80. AUSTRALIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 81. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 82. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 83. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 86. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 87. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 90. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 91. LAMEA NICOTINE REPLACEMENT THERAPY PRODUCTS SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 93. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 94. LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 95. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 96. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 97. BRAZIL SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 98. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 99. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 100. SAUDI ARABIA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 101. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 103. SOUTH AFRICA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 104. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 105. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 106. REST OF LAMEA SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 107.BRITISH AMERICAN TOBACCO PLC: COMPANY SNAPSHOT
TABLE 108.BRITISH AMERICAN TOBACCO PLC: OPERATING SEGMENTS
TABLE 109.BRITISH AMERICAN TOBACCO PLC: PRODUCT PORTFOLIO
TABLE 110.BRITISH AMERICAN TOBACCO PLC: NET SALES,
TABLE 111.BRITISH AMERICAN TOBACCO PLC: KEY STRATERGIES
TABLE 112.22ND CENTURY GROUP INC.: COMPANY SNAPSHOT
TABLE 113.22ND CENTURY GROUP INC.: OPERATING SEGMENTS
TABLE 114.22ND CENTURY GROUP INC.: PRODUCT PORTFOLIO
TABLE 115.22ND CENTURY GROUP INC.: NET SALES,
TABLE 116.22ND CENTURY GROUP INC.: KEY STRATERGIES
TABLE 117.CIPLA LTD.: COMPANY SNAPSHOT
TABLE 118.CIPLA LTD.: OPERATING SEGMENTS
TABLE 119.CIPLA LTD.: PRODUCT PORTFOLIO
TABLE 120.CIPLA LTD.: NET SALES,
TABLE 121.CIPLA LTD.: KEY STRATERGIES
TABLE 122.DR. REDDY’S LABORATORIES LTD.: COMPANY SNAPSHOT
TABLE 123.DR. REDDY’S LABORATORIES LTD.: OPERATING SEGMENTS
TABLE 124.DR. REDDY’S LABORATORIES LTD.: PRODUCT PORTFOLIO
TABLE 125.DR. REDDY’S LABORATORIES LTD.: NET SALES,
TABLE 126.DR. REDDY’S LABORATORIES LTD.: KEY STRATERGIES
TABLE 127.GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
TABLE 128.GLAXOSMITHKLINE PLC.: OPERATING SEGMENTS
TABLE 129.GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 130.GLAXOSMITHKLINE PLC.: NET SALES,
TABLE 131.GLAXOSMITHKLINE PLC.: KEY STRATERGIES
TABLE 132.IMPERIAL BRANDS PLC.: COMPANY SNAPSHOT
TABLE 133.IMPERIAL BRANDS PLC.: OPERATING SEGMENTS
TABLE 134.IMPERIAL BRANDS PLC.: PRODUCT PORTFOLIO
TABLE 135.IMPERIAL BRANDS PLC.: NET SALES,
TABLE 136.IMPERIAL BRANDS PLC.: KEY STRATERGIES
TABLE 137.JOHNSON AND JOHNSON INC: COMPANY SNAPSHOT
TABLE 138.JOHNSON AND JOHNSON INC: OPERATING SEGMENTS
TABLE 139.JOHNSON AND JOHNSON INC: PRODUCT PORTFOLIO
TABLE 140.JOHNSON AND JOHNSON INC: NET SALES,
TABLE 141.JOHNSON AND JOHNSON INC: KEY STRATERGIES
TABLE 142.NJOY COMPANY: COMPANY SNAPSHOT
TABLE 143.NJOY COMPANY: OPERATING SEGMENTS
TABLE 144.NJOY COMPANY: PRODUCT PORTFOLIO
TABLE 145.NJOY COMPANY: NET SALES,
TABLE 146.NJOY COMPANY: KEY STRATERGIES
TABLE 147.PERRIGO COMPANY PLC.: COMPANY SNAPSHOT
TABLE 148.PERRIGO COMPANY PLC.: OPERATING SEGMENTS
TABLE 149.PERRIGO COMPANY PLC.: PRODUCT PORTFOLIO
TABLE 150.PERRIGO COMPANY PLC.: NET SALES,
TABLE 151.PERRIGO COMPANY PLC.: KEY STRATERGIES
TABLE 152.PFIZER INC.: COMPANY SNAPSHOT
TABLE 153.PFIZER INC.: OPERATING SEGMENTS
TABLE 154.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 155.PFIZER INC.: NET SALES,
TABLE 156.PFIZER INC.: KEY STRATERGIES
TABLE 157.ZYDUS CADILA, INC.: COMPANY SNAPSHOT
TABLE 158.ZYDUS CADILA, INC.: OPERATING SEGMENTS
TABLE 159.ZYDUS CADILA, INC.: PRODUCT PORTFOLIO
TABLE 160.ZYDUS CADILA, INC.: NET SALES,
TABLE 161.ZYDUS CADILA, INC.: KEY STRATERGIES
TABLE 162.RUSAN PHARMA LTD: COMPANY SNAPSHOT
TABLE 163.RUSAN PHARMA LTD: OPERATING SEGMENTS
TABLE 164.RUSAN PHARMA LTD: PRODUCT PORTFOLIO
TABLE 165.RUSAN PHARMA LTD: NET SALES,
TABLE 166.RUSAN PHARMA LTD: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
